178
Views
0
CrossRef citations to date
0
Altmetric
Original Article

A Rare Case of Fulminant Acute Postoperative Morganella morganii Endophthalmitis

, MS, , MD & , BS
Pages 123-126 | Received 06 Jun 2021, Accepted 09 Oct 2021, Published online: 22 Nov 2021
 

ABSTRACT

Purpose: The authors present a case of a 60-year-old Indian female presented with sudden loss of vision in the right eye three days after an uneventful cataract surgery which revealed a rare organism and which was treated successfully. Methods: She was diagnosed with acute postoperative endophthalmitis with fulminant disease and on further work up, culture showed Morganella morganii (gram negative bacilli). Results: She was successfully treated with intravitreal imipenem, dexamethasone and vitrectomy. A review of literature was conducted to identify and discuss additional reports on similar cases. As per PubMed search with keywords “Morganella morganii endophthalmitis” this is the best achieved visual outcome to date in a case of acute post-operative Morganella morganii endophthalmitis. Conclusion: Intravitreal imipenem can be considered to treat Morganella morganii endophthalmitis. Aggressive treatment in these patients can help in improving visual outcome.

Key message

  1. In case of Morganella morganii endophthalmitis intravitreal imipenem can be used.

  2. Aggressive and early treatment can improve visual outcomes in a case of fulminant endophthalmitis due to Morganella morganii.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.